Skip to main content

Fiscal Wizard · Single-issue tearsheet

CERT / Jun 22, 2026 Run #7644

CERT

Certara, Inc.

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Composite verdict

D 34.4 / 100
Bearish setup · Trend Following 5 drivers · 5 gates blocking
  • Accumulation/Distribution Line
  • Ichimoku
  • TRIX Zero-Line
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 20th of 47 in Health Information Services

rescore-sweep
Technical synthesisRegime: volatile range
Bull 0%Evidence: High · 14 signals100% Bear
Momentum Bearish 18Mean-reversion Bearish 38

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety +9%
Asset value $6.83Earnings power value $0.52Price $5.54

The discount is mostly unpriced earnings power: price ($5.54) sits between asset value ($6.83) and no-growth earnings power value ($0.52).

Fundamentals Above average

63.2 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Days Sales Outstanding 13
Free Cash Flow Yield 100
Asset Turnover 21
EBITDA Margin 77
Return on Invested Capital 25

Technicals Bearish

5.6 / 100

Bearish setup leads (Accumulation/Distribution Line, Ichimoku, Williams %R); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Accumulation/Distribution Line 8
Ichimoku 20
Williams %R 26

Risk Gates

5 blocking 4 caution

5 guards active, 27 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CERT.